Aaron Kantoff
InvestorBoard Member at Avalo Therapeutics
About
Founder and Managing Partner of Scion Life Sciences with over a decade specializing in founding and investing in biotech companies. Founding board member of Tourmaline Bio, Centessa Pharmaceuticals, and RayzeBio (acquired by Bristol Myers Squibb). Previously Partner at Apple Tree Partners as a venture capital investor and board member of multiple companies including Akero Therapeutics, Corvidia, and Syntimmune.
Colleagues at Avalo Therapeutics
Ashley Ivanowicz
Senior Vice President, Human Resources at Avalo Therapeutics
Chris Sullivan
Chief Financial Officer at Avalo Therapeutics
Colleen Matkowski
Senior Vice President, Global Regulatory Affairs and Quality Assurance at Avalo Therapeutics
Dino C. Miano
Senior Vice President, CMC and Technical Operations at Avalo Therapeutics
Garry A. Neil
Chief Executive Officer at Avalo Therapeutics
Gilla Kaplan
Board Member at Avalo Therapeutics
Jennifer Riley
Chief Strategy Officer at Avalo Therapeutics
Kathleen Cohen
Senior Vice President, Clinical Development Operations at Avalo Therapeutics